Envisia Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Envisia Therapeutics

Access the complete profile.

Envisia Therapeutics Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	Po Box 110065 Rtp, NC 27709

Note: Revenues for privately held companies are statistical evaluations.


Envisia Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Envisia Therapeutics's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Envisia Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Investor Activity

Envisia Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 17, 2016	9	61%	$17 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Envisia Therapeutics is developing and marketing. Envisia Therapeutics doesn't have any recent trademark applications, indicating Envisia Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ENVISIA THERAPEUTICS Pharmaceutical preparations for the treatment and prevention of ocular diseases and conditions	06/08/2017

See all trademarks and details in the Full Report.

Market Share of Envisia Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Envisia Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Envisia Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RESEARCH TRIANGLE INSTITUTE INTERNATIONAL	Durham, NC	100
KBI BIOPHARMA	Durham, NC	89
VELOCITY CLINICAL RESEARCH	Durham, NC	43
FAMILY HEALTH INTERNATIONAL	Durham, NC	37
WORLDWIDE CLINICAL TRIALS	Durham, NC	37
BIOAGILYTIX LABS LLC.	Durham, NC	26

Future Competition: Envisia Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Envisia Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)